Research – Vectrus (VEC) – U.S. Army Determines LOGCAP V Bid Prices Reasonable, Will Proceed with Original Awardees

Friday, February 7, 2020

Vectrus (VEC)

U.S. Army Determines LOGCAP V Bid Prices Reasonable, Will Proceed with Original Awardees

Vectrus Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offer facility and logistics services and information technology and network communications services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations and others.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

U.S. Army Determination. On February 5th, the U.S. Army filed a status report with the U.S. Court of Federal Claims regarding its reexamination of bid prices under the LOGCAP V award. The Army determined the bid prices of the winning awardees are reasonable. Hopefully, this will allow Vectrus to move forward on its awards under LOGCAP V.

Proceeding with Original Awardees. According to the status report, the Army “intends to proceed with the previously awarded LOGCAP V contracts on or after March 2nd.” Recall, in April 2019, Vectrus was awarded LOGCAP V contracts for the CENTCOM and…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research dlh holdings corp- dlhc 1q20 solid start to the year

Thursday, February 6, 2020


DLH Holdings Corp. (DLHC)

1Q20: Solid Start to the Year

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of veteran affairs, Department of health and human services, Department of Defense and other government agencies. It operates primarily through prime contracts and also derives its revenue from agencies of the federal government, primarily as a prime contractor but also as a subcontractor to other Federal prime contractors.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

1Q20 Results. Revenue totaled $52.2 million, compared to $33.8 million last year and above our $51 million estimate. Operating income came in at $3.1 million, compared to $2.6 million last year and in-line with our $3.2 million estimate. Net income totaled $1.6 million, or $0.12 per share, compared to $1.7 million, or $0.13 per share last year and our $1.67 million/$0.13 per share estimate. Higher interest and amortization charges associated with the S3 acquisition impacted the bottom line.

S3 Remains the Driver. S3 generated revenue of $17.3 million in the quarter, This is down from $19.8 million in the fourth quarter of 2019 but we would remind readers that S3 revenues are prone to quarterly fluctuations due to…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research gevo inc- gevo good to be green initiating coverage with outperform rating

Thursday, February 6, 2020

Gevo, Inc. (GEVO)

Good to be Green – Initiating Coverage

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment and the Gevo Development/Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Gevo Development/Agri-Energy is the key revenue generating segment which involves the operation of the Luverne Facility and production of ethanol, isobutanol and related products.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Large market opportunity for low carbon renewable fuels. Visible plan to execute. Attractive proprietary concept geared toward production of low carbon renewable transportation fuels. There is a clear fairway to producing ethanol with a lower carbon footprint and shifting toward renewable transportation fuels with lower carbon footprints. The first two phases have defined targets.

Solid progress to date on Phase 1 and shift toward low carbon ethanol under way. he startup of wind energy and the move toward renewable natural gas (RNG) production are significant marks of progress on Phase 1. Recent contract with…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research – Gevo, Inc. (GEVO) – Good to be Green – Initiating Coverage with OUTPERFORM Rating

Thursday, February 6, 2020

Gevo, Inc. (GEVO)

Good to be Green – Initiating Coverage

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment and the Gevo Development/Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Gevo Development/Agri-Energy is the key revenue generating segment which involves the operation of the Luverne Facility and production of ethanol, isobutanol and related products.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Large market opportunity for low carbon renewable fuels. Visible plan to execute. Attractive proprietary concept geared toward production of low carbon renewable transportation fuels. There is a clear fairway to producing ethanol with a lower carbon footprint and shifting toward renewable transportation fuels with lower carbon footprints. The first two phases have defined targets.

Solid progress to date on Phase 1 and shift toward low carbon ethanol under way. he startup of wind energy and the move toward renewable natural gas (RNG) production are significant marks of progress on Phase 1. Recent contract with…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research – DLH Holdings Corp. (DLHC) – 1Q20: Solid Start to the Year

Thursday, February 6, 2020


DLH Holdings Corp. (DLHC)

1Q20: Solid Start to the Year

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of veteran affairs, Department of health and human services, Department of Defense and other government agencies. It operates primarily through prime contracts and also derives its revenue from agencies of the federal government, primarily as a prime contractor but also as a subcontractor to other Federal prime contractors.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

1Q20 Results. Revenue totaled $52.2 million, compared to $33.8 million last year and above our $51 million estimate. Operating income came in at $3.1 million, compared to $2.6 million last year and in-line with our $3.2 million estimate. Net income totaled $1.6 million, or $0.12 per share, compared to $1.7 million, or $0.13 per share last year and our $1.67 million/$0.13 per share estimate. Higher interest and amortization charges associated with the S3 acquisition impacted the bottom line.

S3 Remains the Driver. S3 generated revenue of $17.3 million in the quarter, This is down from $19.8 million in the fourth quarter of 2019 but we would remind readers that S3 revenues are prone to quarterly fluctuations due to…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research akazoo song selective with its opportunities for expansion

Wednesday, February 5, 2020

Akazoo (SONG)

Selective With Its Opportunities For Expansion

Akazoo is a global, on-demand music and audio streaming and media and AI technology company, founded in 2010, with a focus on emerging markets and a presence in 25 countries. Akazoo’s premium service provides subscribers with unlimited online and offline high-quality music streaming access to a catalog of over 45 million songs on an ad-free basis. Akazoo uses patented AI for music recommendations and offers online and offline listening. Akazoo’s free, ad-supported radio service consists of over 80,000 stations and exists as separate services and application. As consumers across the globe continue to shift their media consumption to mobile devices, Akazoo is equipped with a world-class mobile application and user experience which works seamlessly across a multitude of mobile devices and provides a high-quality user experience across a range of mobile networks from 2g to 4g LTE and soon 5g.

Michael Kupinski, DOR, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Shares significantly off of recent highs. We do not believe that there is a fundamental reason for the recent weakness. The SONG shares are down 39% from its recent high of $6.74 in September, 2019.

Recent article highlights competition in India. Akazoo is not in India given that management believed that it would not be able to monetize the subscribers and that India would be unprofitable. The company chooses markets that it believes will…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research orion group holdings orn significant industrial award pushes ytd awards to 87 million

Wednesday, February 5, 2020

Orion Group Holdings (ORN)

Significant Industrial Award Pushes YTD Awards to $87 million

Orion Group Holdings, based in Houston, Texas, is a specialty construction company within the Marine and Industrial Construction sectors, with operations focused in the continental United States and Caribbean. Revenue is split roughly 50/50 between a Marine Construction segment that provides marine facility, pipeline and structural construction services and a Commercial Concrete segment that provides turnkey concrete services in the light commercial and structural construction markets.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

$47 million award is first sign of emerging industrial strategy. The multi-discipline work for the Port of New Orleans on the Nashville Terminal in New Orleans is the first industrial award. Work includes demolishing a warehouse, repairing/upgrading existing wharf infrastructure, and modifying/installing rails for four container cranes. Work is longer term, slated to begin this quarter and run six quarters through 3Q2021.

Combined with prior concrete awards of $40 million, YTD awards total $87 million. The longer term industrial award complements the six shorter concrete jobs previously awarded that begin this quarter and…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Containing Coronavirus has Caused an “Oil Demand Shock”

Are Oil Markets Overreacting to the Spread of Coronavirus?

(Note: companies that
could be impacted by the content of this article are listed at the base of the
story [desktop version]. This article uses third-party references to provide a
bullish, bearish, and balanced point of view; sources are listed after the
Balanced section.)

The spread of the coronavirus continues to accelerate with China’s Health Commission reporting 361 deaths in mainland China which now surpasses the 249-death count associated with the SARS virus.  Globally, the coronavirus has resulted in more than 800 deaths and has affected more than 17,000 people. The virus is spreading to other nations and is now affecting industries beyond travel, vacation and health.  The energy industry has been hit especially hard with oil prices crashing.  West Texas Intermediate (WTI) oil prices began 2020 on a high note peaking above $63 per barrel on January 2nd.  Since then, the price of oil has fallen 20% to a price near $50 per barrel.  Is the market overreacting to the impact of the virus or are market concerns warranted?

 

On the Bright Side

The drop in oil price is fear related, not demand
related.
  Some analysts believe the drop in oil price is overblown.  Manish Raj, chief financial officer at Velandera Energy, for example, says that there is “no doubt that the actual oil-demand reduction resulting from the coronavirus will be temporary at best.”  Jay Park, chief executive officer at ReconAfrica, says there is “no visible impact to demand just yet” and believes the price movement is being driven by fear.

Oil prices are tracking the SARS outbreak, but this time
is different
.  Oil price declined 20% during the SARS outbreak in 2003, a similar drop to that of the coronavirus.  However, Bandana Hari, founder and CEO of energy markets consultancy Vanda Insights, points out that the biggest reason for the decline in oil prices in 2003 was not SARS, but the U.S. invasion of Iraq.  Absent further issues in the Middle East, one could conclude that the impact on oil prices should not be a severe as in 2003.

A supply response may be coming.  OPEC responded to the drop in oil prices by scheduling an emergency meeting on February 4-5 to discuss a cut in production.  Analysts believe OPEC could cut as much as one million barrels per day of production.  This would have a significant impact on a market that produces 80 million barrels per day.

Governments are taking steps to contain the virus.  Nations are responding by limiting flights to and from China and quarantining new arrivals.  The United States, which has reported 11 cases of the virus, allows only a handful of airports to accept flights from China.  Other countries are following suit.  Should the virus be largely contained to China, the impact on oil demand could prove to be less than originally feared.

 

Cause for Concern

China is the world’s largest oil importer. China consumes approximately 20% of the 80 million barrels of oil consumed daily.  Chinese oil demand has dropped 3 million barrels of oil a day, or 20% of its total consumption in response to the coronavirus according to several sources within the Chinese energy industry.  According to Bloomberg, the impact is probably the largest demand shock the oil market has suffered since the financial crisis of 2008-09 and the most sudden since the attacks of September 11, 2001.

The virus is beginning to affect the entire China
economy. 
The BBC reports that China’s central bank is prepared to pump 1.2 trillion yuan ($168 billion) into its economy.   One state media outlet estimates that the virus could reduce China’s already fragile economic growth rate by two percentage points, which would equate to $62 billion in lost growth.  Such a shock to China’s economy will undoubtedly have a significant impact on the country’s demand well beyond the virus’s containment.

Suppliers are less able to counter the drop in demand
than in the past. 
OPEC has responded to past declines in oil prices by cutting supply and is attempting to do so again.  Unlike the past, however, OPEC’s influence on oil prices has decreased by the growth of the U.S. oil market.  OPEC currently produces approximately 40% of the world’s oil production.  Consequently, its ability to support oil prices by lowering production is questionable.

 

Big Picture

Whether the oil markets are overreacting to the spread of the coronavirus remains to be seen.  Analysts who say the markets are reacting to fears of the virus getting worse are probably right.  On the other hand, analysts who point out the importance of China as a consumer of oil are also right.  The actual impact on oil demand is small at this point but has the potential to grow exponentially, just like the virus.  And, if it does, there will be little producers can do to offset the drop in demand.

Suggested Reading:

C1
Technology’s Potential to Manufacture Candidate Vaccines Against Coronavirus

The Quick Spread of Coronavirus is
Impacting Global Economies and Markets

Sources

https://www.cnbc.com/2020/02/03/oil-falls-to-a-more-than-1-year-low-below-50-on-fears-the-coronavirus-will-slow-global-growth.html, Pippa Stevens, CNBC, February 3, 2020

https://www.cnbc.com/2020/01/28/ceo-coronavirus-impact-on-oil-prices-not-entirely-comparable-to-sars.html?recirc=taboolainternal, Abigail Ng, CNBC, January 28, 2020

https://www.cnn.com/2020/01/31/economy/china-economy-coronavirus/index.html, Laura He, CNN Business, January 31, 2020

https://www.bbc.com/news/business-51347497, BBC, February 2, 2020

https://www.ncbi.nlm.nih.gov/books/NBK92473/, Jong-Wha Lee and Warwick J. McKibbin, “Learning from SARS: Preparing for the Next Disease Outbreak, 2004

https://www.barrons.com/articles/oil-prices-slump-on-fears-the-worst-of-coronavirus-is-yet-to-come-51580468401, Myra P. Saefong, January 31, 2020

https://www.bloomberg.com/news/articles/2020-02-02/china-oil-demand-is-said-to-have-plunged-20-on-virus-lockdown, Alfred Cang, Javier Blas and Sharon Cho, Bloomberg, February 2, 2020

Research – Akazoo (SONG) – Selective With Its Opportunities For Expansion

Wednesday, February 5, 2020

Akazoo (SONG)

Selective With Its Opportunities For Expansion

Akazoo is a global, on-demand music and audio streaming and media and AI technology company, founded in 2010, with a focus on emerging markets and a presence in 25 countries. Akazoo’s premium service provides subscribers with unlimited online and offline high-quality music streaming access to a catalog of over 45 million songs on an ad-free basis. Akazoo uses patented AI for music recommendations and offers online and offline listening. Akazoo’s free, ad-supported radio service consists of over 80,000 stations and exists as separate services and application. As consumers across the globe continue to shift their media consumption to mobile devices, Akazoo is equipped with a world-class mobile application and user experience which works seamlessly across a multitude of mobile devices and provides a high-quality user experience across a range of mobile networks from 2g to 4g LTE and soon 5g.

Michael Kupinski, DOR, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Shares significantly off of recent highs. We do not believe that there is a fundamental reason for the recent weakness. The SONG shares are down 39% from its recent high of $6.74 in September, 2019.

Recent article highlights competition in India. Akazoo is not in India given that management believed that it would not be able to monetize the subscribers and that India would be unprofitable. The company chooses markets that it believes will…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research – Orion Group Holdings (ORN) – Significant Industrial Award Pushes YTD Awards to $87 million

Wednesday, February 5, 2020

Orion Group Holdings (ORN)

Significant Industrial Award Pushes YTD Awards to $87 million

Orion Group Holdings, based in Houston, Texas, is a specialty construction company within the Marine and Industrial Construction sectors, with operations focused in the continental United States and Caribbean. Revenue is split roughly 50/50 between a Marine Construction segment that provides marine facility, pipeline and structural construction services and a Commercial Concrete segment that provides turnkey concrete services in the light commercial and structural construction markets.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

$47 million award is first sign of emerging industrial strategy. The multi-discipline work for the Port of New Orleans on the Nashville Terminal in New Orleans is the first industrial award. Work includes demolishing a warehouse, repairing/upgrading existing wharf infrastructure, and modifying/installing rails for four container cranes. Work is longer term, slated to begin this quarter and run six quarters through 3Q2021.

Combined with prior concrete awards of $40 million, YTD awards total $87 million. The longer term industrial award complements the six shorter concrete jobs previously awarded that begin this quarter and…



Get the full report on Channelchek desktop.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research – TherapeuticsMD (TXMD) – Low-dose Bijuva NDA filed, Approval is Anticipated in Q4 2020<

Tuesday, February 4, 2020

TherapeuticsMD Inc. (TXMD)

Low-dose Bijuva NDA filed, Approval is Anticipated in Q4 2020

(current) TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD’ and BocaGreenMD’ brands. The company is currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. It is also evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Supplement new drug application for Bijuva is submitted. Bijuva is the first and only FDA approved (on October 28 of 2018) hormone therapy of bio-identical estradiol in combination with bio-identical progesterone (P+E, 1 mg/100 mg) for the treatment of moderate to severe vasomotor symptoms due to menopause. The new drug application (NDA) prior-approval efficacy supplement was submitted to the U.S. Food and Drug Administration (FDA) for the lower dose (0.5 mg/100 mg) capsules of Bijuva. The company anticipates a decision by the FDA in Q4 2020. We think this will provide options and dose flexibility for patients.

Commercial uptake continues to grow.  The company has three commercial products, all launched within the past 1.5 years. The company is primarily focused on the first commercial product Imvexxy that reached $4.77 mm sales in Q3 2019, while Bijuva and Annovera reached $0.49mm and $0.40mm. We think the product uptake continues to grow for…




Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research – Endeavour Silver (EXK) – Lowering Estimates to Reflect 2020 Production Guidance

Tuesday, February 04, 2020

Endeavor Silver (EXK)

Lowering Estimates to Reflect 2020 Production Guidance

Endeavour Silver Corp is a precious metal mining company. The company is primarily engaged in silver mining and owns three high-grade, underground, silver-gold mines in Mexico. Its other business activities include acquisition, exploration, development, extraction, processing, refining and reclamation. It is also involved in exploration activities in Chile. The company is organized into three operating mining segments, Guanacevi, Bolanitos and El Cubo, which are located in Mexico as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico and Chile.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

2020 production guidance. Endeavour forecasts silver production in the range of 3.0 million to 3.5 million ounces and gold production in the range of 38,000 to 44,000 ounces. In 2019, Endeavour produced 4.0 million ounces of silver and 38,907 ounces of gold. While 2020 silver production is expected to decline relative to 2019, management expects better operating and cost performance from Guanacevi and Bolanitos. On a silver equivalent basis, EXK expects to produce between 6.0 million and 7.0 million ounces compared to 7.1 million ounces in 2019.

Updating estimates. While we are making no changes to our 2019 estimates, we have revised our 2020 EPS and EBITDA estimates to $0.04 and $31.7 million from $0.08 and…



Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.
 

Research therapeuticsmd txmd low dose bijuva nda filed approval is anticipated in q4 2020

Tuesday, February 4, 2020

TherapeuticsMD Inc. (TXMD)

Low-dose Bijuva NDA filed, Approval is Anticipated in Q4 2020

(current) TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD’ and BocaGreenMD’ brands. The company is currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. It is also evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Supplement new drug application for Bijuva is submitted. Bijuva is the first and only FDA approved (on October 28 of 2018) hormone therapy of bio-identical estradiol in combination with bio-identical progesterone (P+E, 1 mg/100 mg) for the treatment of moderate to severe vasomotor symptoms due to menopause. The new drug application (NDA) prior-approval efficacy supplement was submitted to the U.S. Food and Drug Administration (FDA) for the lower dose (0.5 mg/100 mg) capsules of Bijuva. The company anticipates a decision by the FDA in Q4 2020. We think this will provide options and dose flexibility for patients.

Commercial uptake continues to grow.  The company has three commercial products, all launched within the past 1.5 years. The company is primarily focused on the first commercial product Imvexxy that reached $4.77 mm sales in Q3 2019, while Bijuva and Annovera reached $0.49mm and $0.40mm. We think the product uptake continues to grow for…




Get the full report on Channelchek desktop.

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst
certification and important disclosures included in the full report. 
NOTE: investment decisions should not be based upon the content of
this research summary.  Proper due diligence is required before
making any investment decision.